The Indian pharmaceutical export sector has registered a robust 14% year-on-year growth in the first quarter of calendar 2026, reaching USD 8.4 billion, according to the latest data released by…
New Findings in Pulmonary Fibrosis and Post-COVID Lung Disease Pulmonary fibrosis after COVID-19 is leaving thousands of patients struggling to breathe every day. Many are desperately searching for treatments that…
In 2025, the global fight against HIV has seen both major medical progress and serious challenges, according to recent reports from UNAIDS and the World Health Organization. Dolutegravir-Based Regimens Leading…
paxlovid-pf-07321332-ritonavir-covid-19-article-53-procedure-conditions-use-conditions-distribution_enDownload MEDICINAL PRODUCT FOR USE 1. Name of the medicinal product for use: PAXLOVID 2. Active substance(s): Nirmatrelvir and ritonavir 3. Pharmaceutical form: Film-coated tablets 4. Route of administration: Oral use…